Bone marrow donor from Germany becomes recipient’s maid of honour – DNA India

For 30-year-old Steffi Mac, life took an unexpected turn, when she was just 24-year-old brimming with ideas and dreams. The young woman was detected with Acute Lymphoblastic Leukemia (ALL) or in simple terms blood cancer.

Immediate consultation with specialist doctors revealed that the only way to save Steffi's life was Bone Marrow Transplant. However, the lone solution came up with its own challenges.

As Steffi was the only child of her parents, there was no way that siblings could donate their bone marrow to her. Another setback was that her parents also could not donate the bone marrow to her because of matching issues.

She was taken to Christian Medical College, Vellore, in December 2013 where considering the risk to her life, the doctors and the hospital immediately started looking for a bone marrow donor for her.

However, not a single matching donor was found in the country. Eventually, the doctors found a matching donor from Germany in the DKMS registry, the world's largest bone marrow donor registry, and the transplant was carried out in March 2014. The transplant and the subsequent recovery was a painful process, but being a fighter, Steffi won the battle against cancer.

However, inside her mind, she desperately wanted to meet the person who saved her life. After innumerable requests and necessary permissions, she managed to get the email ID of the donor, wrote an emotional mail and then phone calls started between the two.

"I was communicating with her through emails and phone, but I just wanted to meet her in person, hug her, and tell her that she changed my life. For this, I went to Germany and when we met at the airport, we just cried like anything. I stayed with her for 10 days and it is a bond which cannot be explained in words," Steffi said.

Steffi added when she eventually got married last year, Aylin flew in from Germany with her friend and she was my maid of honour. Now, a lecturer with an Ahmedabad-based college and a corporate trainer, Steffi is actively working to create awareness on the issue of bone marrow donation and spoke on her journey against blood cancer on the occasion of World Marrow Donor Day organised by DATRI, India's largest unrelated blood stem cell donor registry.

On the occasion, three donors and their respective survivors were also present and spoke on the issue. The donorsDivyesh Shah, Binal Patel and Yashvant Polkar have saved a life and family by donating their blood stem cells.

View post:
Bone marrow donor from Germany becomes recipient's maid of honour - DNA India

Tumor Marker Testing Market Size, Growth, Trends and 2023 Forecast Report – OnYourDesks

A biomarker is any cellular, physical, chemical, or molecular change that can be noted and a normal or abnormal process in human body can be studied. The effects of treatment, the presence, progress or risk for a disease can be checked by studying any alteration in the normal amount of a biomarker. A tumor marker, like a biomarker, is a naturally occurring substance in the body. An increased quantity of a tumor marker can show the presence of a cancer. Some tumor markers are related to several different types of cancer, while some are specific to one type of cancer. Tumor markers may also increase with non-cancerous conditions. A tumor marker can be prepared by cancer cells or by the body in response to cancer.

There are many different types of tumor markers such as human chorionic gonadotropin (HCG or b-HCG), cancer antigen 15-3 (CA15-3), alpha-fetoprotein (AFP), carbohydrate antigen 19-9 (CA19-9), cancer antigen 125 (CA125), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA). Tumor markers can provide information that can be used for screening for cancer, diagnose cancer, determine stage of cancer, determine a persons prognosis, guide treatment, monitor treatment, and determine recurrence of the cancer. Some markers can be used in people with family history of a particular cancer. Prostate specific antigen can be used to screen for prostate cancer. Tumor markers can be used to help determine how far the cancer has spread into other tissues or organs. Some markers are used to determine how aggressive a cancer is likely to be. Some markers may help doctors predict what treatments the cancer is likely to respond to.

A tumor marker test is done to make available a baseline level before treatment, when any type of cancer is suspected, to check if cancer has returned after treatment being given, and to check a persons reaction to cancer treatment. Tumor markers are molecules found in urine, blood, and body tissues. It is a protein found in large amounts in presence of cancer. Hence, measuring the levels of tumor markers may help in detecting the presence of cancer. Presence of a tumor in body stimulates the production of tumor markers from tumor or non-tumor cells. The tumor marker testing market has been categorized based on diagnostic method, type of cancer, and technology employed for cancer detection. Organ specific tumor marker: bladder, breast, colorectal, gastrointestinal, liver, lung, oral, ovarian, pancreatic, prostatic, skin testicular cancer, leukemia, lymphoma, and others; Clinical laboratory methods for measuring tumor markers: Abbott diagnostics AxSYM, Roche Diagnostics System, Fischer Thermo Scientific B.R.A.H.M.S KRYPTOR and others; New technologies for cancer diagnostics: Monoclonal antibodies, proteomics, new protein markers, stem cell markers, DNA microassays and others; Clinical methods for cancer diagnosis: Screening, imaging, theranostics, sigmoidoscopy and others.

Browse more detail information about this report visit at at https://www.transparencymarketresearch.com/tumor-marker-testing-market.html

Currently, cancer is the one of the leading causes of death in North America and Europe. North America holds the largest share of the tumor marker testing market, followed by Europe, due to vast discoveries and innovations for detecting cancer in early stages. Major factors driving the tumor marker testing market in these regions are rising incidence of cancer disease, increase in geriatric population, ongoing research in the field of cancer detection, and improved government reimbursement policies. However, high cost acts as a major restraint of the market.

Geographically, North America held the larger market share, followed by Europe. High research on tumor marker and increasing number of cancer patients in these regions are likely to boost the tumor marker testing market. However, affordability has become a restraining factor in this market in developing regions such as Asia Pacific and Latin America. However, the tumor marker testing market in Asia Pacific is expected to experience strong growth.

Major players in the tumor marker testing market are Abbott Diagnostics Ltd., Affymetrix, Inc., Agilent Technologies, Inc., Beckman, Dickinson and Company (BD) Diagnostics, BioCurex, BioModa, Inc., Clarient, Inc., Correlogic Systems, Inc., Epigenomics AG, Gen-Probe, Inc., Hologic, Inc., Roche Diagnostics Corp., and Veridex LLC, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request For Custom Research At https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=2253&source=atm

The study is a source of reliable data on: Market segments and sub-segments Market trends and dynamics Supply and demand Market size Current trends/opportunities/challenges Competitive landscape Technological breakthroughs Value chain and stakeholder analysis

The regional analysis covers: North America (U.S. and Canada) Latin America (Mexico, Brazil, Peru, Chile, and others) Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg) Eastern Europe (Poland and Russia) Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand) Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report: A complete backdrop analysis, which includes an assessment of the parent market Important changes in market dynamics Market segmentation up to the second or third level Historical, current, and projected size of the market from the standpoint of both value and volume Reporting and evaluation of recent industry developments Market shares and strategies of key players Emerging niche segments and regional markets An objective assessment of the trajectory of the market Recommendations to companies for strengthening their foothold in the market

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request for TOC of This Report visit at https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2253&source=atm

More here:
Tumor Marker Testing Market Size, Growth, Trends and 2023 Forecast Report - OnYourDesks

3-day blood drive in Bathurst supports toddler with rare disease – CBC.ca

A three-day blood drive is being held in Bathurstto help increase the supply ofblood and plasma to help a toddler living with a rare disease.

Mavrik Hampewas only six months old when he was diagnosed withX-linked agammaglobulinemia (XLA), a disorder that affects the body's ability to fight infection.

"He was displaying signs of frequent infections that he just wasn't recovering from and infections that could cause a lot of damage for a little one," said his mother, Diane McKiel.

Mavrikhad multiple bouts of pneumonia along with the infections before a blood test showed he had no neutrophils, a type of white blood cell.

"They sent us immediately to the IWK in a plane and after a few days he wasn't producing any antibodies and they sent away for genetic testing."

At that point, X-linkedagammaglobulinemiawas confirmed.

McKielsaidMavrik, now 14 months old, will never produceantibodies in his blood to fight infections. He will require treatments of human immune globulin for the rest of his life.

"Everybody's learning through this process, both myself and his health-care providers."

McKieldescribes what they were living through as survival mode as they tried to find out what was wrong withMavrik.

"You just take everything day by day and you put your trust in the hands of many doctors that were involved."

McKielsaid blood donations are important forMavrik's survival because thehuman immune globulin is a plasma derived treatment from blood.

"This particular product, it takes thousands of donors to make this very concentrated formula ofimmune globulin."

He receives the treatment each month. He hasn't had a fever since he started the treatment.

"We couldn't have asked for a better outcome," said McKiel.

"As a mom, I was trying to figure out what can I do for him and what I can do for him is just make his story to be known and for people to be encouraged to go donate blood for this very reason."

McKiel had only given blood twice before her son's illness. Now she better understands theimportance of giving blood.

"I will be a lifetime donor now," she said. She has also registered as a stem-cell donor.

The blood drive will be held at theK.C. Irving Centre in the Paul Ouellette Room.

Donations can be made Monday from4:30-8:30 p.m., Tuesday from noon-3 p.m. and 4:30-7:30 p.m. and onWednesday from 1-3 p.m.and then 4:30-7:30 p.m.

"We will be there as a family throughout," said McKiel. "I want the city of Bathurst to see what they're doing for him. There's a little boy you're here helping and we're so happy and so grateful."

Visit link:
3-day blood drive in Bathurst supports toddler with rare disease - CBC.ca

Im pleading with you please donate blood to help save my baby girl without it shell die – The Sun

A MUM is pleading for people to donate blood - as without blood donors her baby girl would die.

Adeline Davidson, three, has been left the size of a one-year-old after being struck by a rare blood cancer that causes bruising and tiredness.

14

And now her mum Steph, 25, is sharing her story in the hopes that more people will donate blood - which will keep children like Adeline alive.

She said: "I felt that sharing Adelines journey would encourage more people to register to become a stem cell donor or to donate blood.

"After seeing a little child go through this, anyone with a good heart would want to help."

Former medical administrator Steph and her husband Jordan, 27, from Alness in Scotland, welcomed their daughter Adeline in November 2016 but her birth was marred by a bowel obstruction which required surgery.

14

14

Adeline recovered well but Steph noticed that she was always small for her age, and at the age of one she was wearing clothes aged up to six months old.

In 2018, Steph made an appointment to see a paediatrician but the four-month wait delayed this until February 5, 2019.

The paediatrician noted how pale Adeline looked and decided to do some blood tests.

Steph said: "Adeline struggled putting on weight and going up a clothes size, so at one she was still in size three to six months.

14

14

"Now, at almost three years old she wears 12 to 18 months.

"I had been complaining about her weight and height for a while, but I eventually got an appointment with a paediatrician and had to wait four months.

"She hadnt put weight on for 18 months and was much smaller than other kids her age.

"I always put it down to her bowel problems from birth, but little did we know there was something else unusual with Ads.

14

"The paediatrician wasnt that interested and said she appeared fine, just slightly pale. He took blood tests to check her iron levels."

Just a few hours after Adeline's blood tests Steph received a call asking her to come back in immediately - as the tests showed possible blood cancer.

Steph and Jordan were told to prepare for the worst and the fact Adeline may not ever be able to come home.

I was looking at Adeline, who to me was a healthy, happy, beautiful girl, but they were telling me she was seriously ill it didnt make sense

Steph said: "A few hours later I got a phone call asking to take Adeline in for results.

"I hesitate because it was a long way to go, so he told me over the phone that her bloods indicated a serious problem possibly blood cancer.

"He told us to prepare for not coming home. My heart just stopped, I couldnt believe it and I was hysterical.

14

14

"I was looking at Adeline, who to me was a healthy, happy, beautiful girl, but they were telling me she was seriously ill it didnt make sense."

Initially, doctors suspected leukaemia but when Adeline was transferred to Aberdeen Hospital, further tests confirmed that it wasnt leukaemia, but doctors were no closer to a diagnosis.

Adeline was tested for chromosome mutations, genetic conditions, other types of cancer and doctors are now testing her genomes to find a diagnosis.

Steph added: "There are hundreds of conditions shes been tested for and not one has she tested positive for.

The genome testing theyre doing now consists of putting her DNA sequencing into a pool of other undiagnosed or rare diagnoses and looking for any similarities among them."

Adeline has very low platelets, red blood cell and white blood cell counts, causing bruises, petechia, tiredness, breathlessness and paleness.

In March, doctors believed Adeline could have myelodysplasia, a blood cancer and bone marrow failure, but she shows signs which extend beyond this diagnosis, although it hasnt been confirmed or ruled out.

14

14

While searching for a stem cell match, Adelines blood tests have been reviewed internationally, in Canada and Germany among other countries, to widen the search.

Adeline needs a bone marrow transplant to save her life, but no full matches have been found yet so blood transfusions keep her stable until a match is found.

Low blood counts put Adeline at risk of infection, internal bruising and bleeding out through a small cut as her blood cannot clot as usual.

And since her diagnosis, Adeline has had to be pulled out of nursery for fears of infection or falling which would have devastating impacts on her weakened system.

However, Steph insists that her battle with this mystery illness hasnt dimmed Adelines spirits as she maintains her lively personality and refuses to stop having fun.

What is myelodysplasia?

Myelodysplasia is a type of rare blood cancer where you don't have enough healthy blood cells.

It's also known as Myelodysplastic syndromes (MDS).

There are many different types of MDS. Some types can stay mild for years and others are more serious.

MDS can affect people of any age, but is most common in adults aged 70 to 80 years.

Normally, the spongy tissue found inside bones (bone marrow) produces:

But in MDS, your bone marrow doesn't make enough of these healthy blood cells. Instead, it makes abnormal cells that aren't fully developed (immature).

As the condition develops, your bone marrow gets gradually taken over by the immature blood cells, which don't work properly.

They squeeze out the healthy ones, making the number of cells that manage to get into the bloodstream lower and lower.

The condition can develop slowly (indolent) or quickly (aggressive), and in some people it can develop into a type of leukaemia calledacute myeloid leukaemia (AML).

Source: NHS

She said: "It was planned that Adeline would have a Hickman line put in to allow blood to be taken, transfusions to be given, and any medicine can go through the lines too.

"This was the best news because it was becoming traumatic for Ads as each time she had to get bloods taken, it took five attempts.

"Her veins were so weak and small, so theyd often collapse or move when the needle went in.

"She was an absolute star during the operation and calls her lines her toggles.

"Shes not phased in the slightest with this new accessory.

14

14

"The first diagnosis we got was myelodysplasia in March, a form of blood cancer and bone marrow failure.

"For the last few months, theyve started to steer away from this diagnosis as Adeline has moments of stability and symptoms which arent covered by that diagnosis.

"It hasnt been ruled out, but it could be something else.

"Adelines bone marrow doesnt produce enough red blood cells, platelets or white blood cells so she needs transfusions once every two weeks.

"When she needs platelets, she bruises easily and has little patches of petechia (red or purple spots) on her body.

"When she needs red blood cells, she becomes pale, tired, clumsy and breathless.

14

"Platelets help our blood clot when we bruise or cut ourselves, so when Adelines are low, she has a high risk of bleeding out through a cut or bleeding internally from bruising.

"White blood cells help fight infection, so when Adelines are low, she has a high risk of getting an infection and her body struggles to fight it off.

"Even though Adeline is poorly, you wouldnt be able to tell. Shes a lovely, lively, funny, beautiful little girl and this illness hasnt stopped her having fun."

Steph is hoping encourage more people to donate blood or become stem cell donors and has already seen almost 3000 more donors sign up and help save her daughters life.

14

TWO MIRACLES I refused chemo & beat cancerthen got pregnant after docs said I'm infertile

A MIRACLE WILL HAPPEN Dog the Bounty Hunter was in denial over late wife Beths cancer

HEART SHATTERING My son has brain cancer after we thought he had blocked nose and headache

TOXIC COCKTAIL Warning as 100,000 people in US get cancer from chemicals in drinking water

'SHE'S AT PEACE' Cancer blogger, 23, dies two years after being diagnosed with rare tumour

KIN'S WIN Ten women from one family are celebrating after they ALL beat breast cancer

FINAL BELL Hospital removes 'cruel' bell rang by patients at end of their cancer treatment

A MUM'S LOVE My baby needed a liver transplant to cure her cancer - I didn't think twice

LIFE SAVINGS We've spent our life savings on hospital parking while our girl fights cancer

She added: "Through all our awareness and fundraising, we are close to 3000 new donors signing up and many have donated blood to help Adeline.

"Peoples donations keep Adeline stable, and they can save so many other lives too.

"Thank you to everyone who is registered and to all those who have donated, you are keeping our daughter alive."

To see more about Adelines journey, visitwww.instagram.com/adelinebluesjourney_x

We pay for your stories! Do you have a story for The Sun Online news team? Email us at tips@the-sun.co.uk or call 0207 782 4368 . You can WhatsApp us on 07810 791 502. We pay for videos too. Click here to upload yours.

Continue reading here:
Im pleading with you please donate blood to help save my baby girl without it shell die - The Sun

Cell Harvesting Systems Market research to Exhibit Significant Incremental Dollar Opportunity During the Forecast Period 2016-2026 – Analytics News

Cell harvesting is a technique of collecting stem cells for regenerate, transplant or repair the damaged organ with healthy functioning ones.Cell harvestingis considered as an important step in biopharmaceutical manufacturing industry that can directly affect the product quality and related downstream processes. Stem cells harvesting helps in treating with diseases namely cancers, blood disorders, immune deficiency diseases and various injuries. This therapy is also beneficial for burn victims which help them in grafting new skin cells as a replacement for damaged ones.

Many companies are focusing on regeneration of myocardial tissue by injection of cell graft consist of adult stem cells from the patients for manufacturing regenerating medicines. For the treatment of eye diseases new healthy cells are also be grown. For harvesting bone marrow a companies are manufacturing devices with passive flexible drilling unit and suction mechanism which will help in reducing the invasiveness of bone marrow transplantation.Cell harvesting systemhelps in reducing the invasiveness of bone marrow aspiration from the iliac bone with less punctures. Moreover, helps in reducing procedure time and contamination by T-cells.

Request to Sample of Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-1754

Cell Harvesting Systems Market:Drivers and Restraints : Cell Harvesting Systems Market are witnessing maximum growth owing to increase bone marrow transplantation procedures attributed to high prevalence of blood cancer and anemia. Moreover, improving healthcare expenditure, survival rate after treatment, increasing investment in logistic services, expansion bone marrow transplant registry for heart along with neuronal disorders and growing per capita healthcare expenditure. However, high cost of cumbersome treatment, lack of reimbursement policies, immunological rejection, viable cell density, and identification of stem cells in adult tissues, and complications during cell harvesting and inadequate number of HSCs cells for transplantation is a major barrier to the cell harvesting systems market.

Cell Harvesting Systems Market:Segmentation : The cell harvesting systems market has been classified on the basis of techniques, application and end user. Based on techniques, the cell harvesting systems market is segmented into the following: Altered Nuclear Transfer, Blastomere Extraction Based on application, the cell harvesting systems market is segmented into the following: Bone Marrow, Peripheral Blood, Umbilical Cord Blood, Adipose Tissue, Based on end-user, the cell harvesting systems market is segmented into the following: Research Centers, Academics Institutes, Diagnostic Labs, Hospitals

Cell Harvesting Systems Market:Overview :Cell harvesting systems market witnessed substantial growth owing to equipment efficacy and accuracy during stem cells harvest. By application type, bone marrow aspiration is anticipated to hold the major share in the cell harvesting systems market owing to less process error, safe and simple procedure and less side effects. People suffering from Leukemia eligible for bone marrow transplant, is expected to contribute highest share in the global cell harvesting systems market. Cell harvesting systems helps in enhancing proper pigmentation in scar reconstruction which encourage companies for continuous technology advancement in both cell isolation techniques and downstream purification processes.

Request to View TOC @https://www.futuremarketinsights.com/toc/rep-gb-1754

Cell Harvesting Systems Market: Region-wise Outlook : Depending on geographic region, cell harvesting systems marketis segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Asia Pacific dominates the cell harvesting systems marketfollowed by Europe, Japan and North America owing to high concentration of bone marrow stem cells harvesting centers and registries along with skilled doctors for the process of harvesting stem cells in these regions. Asia Pacific, Middle East and Africa hold huge potential and shows substantial growth in terms of wide acceptance of new technologyowing to awareness among population, increasing healthcare expenditure along with high number of potential candidate for the procedure.

Cell Harvesting Systems Market:Key Players :Key players of cell harvesting systems market are PerkinElmer Inc. Tomtec, Bertin Technologies, TERUMO BCT, INC., hynoDent AG, Avita Medical, Argos Technologies, Inc., SP Scienceware, Teleflex Incorporated., Arthrex, Inc., Thomas Scientific, BRAND GMBH

Continued here:
Cell Harvesting Systems Market research to Exhibit Significant Incremental Dollar Opportunity During the Forecast Period 2016-2026 - Analytics News

Tecumseh girl still looking for bone marrow donor – BlackburnNews.com

Four year old Zoe Dudzianiec (Provided by Katelyn Bedard Bone Marrow Association) By Maureen RevaitSeptember 19, 2019 5:07am

A young Tecumseh girl suffering from a rare blood disorder needs to find a stem cell match.

Zoe Dudzianiec has Diamond-Blackfan Anemia. In simple terms, that means her body doesnt produce the red blood cells she needs to live. She needs a blood transfusion every 10-14 days and nightly chelation therapy to battle the side effects of the blood transfusions.

It can actually cause her to be blind, deaf, it can cause seizures, hearing loss, lots of nasty side effects, said Heidi Dudzianiec, Zoes mother. Zoe is basically maxed out on all the doses of her chelation therapy so there are side effects from it.

Zoe will have to continue this therapy for the rest of her life if a stem cell match or bone marrow donor is not found.

Heidi said theyve been searching for a match for two and a half years and out of 60 million possible donors worldwide theyve found two possible donors.

They rate the matches out of ten, basically. The two they found for Zoe were an eight-out-of-10, but the first one only had a 50 per cent survival rate, which was very bad, and the second one they said there was a very high chance of it reacting with her body, said Heidi.

Doctors deemed the matches not suitable for transplant.

The Katelyn Bedard Bone Marrow Association is holding a Get Swabbed event in conjunction with the Childrens Fest happening Saturday and Sunday, September 21 & 22 at Central Park Athletics in hopes of getting more people on the registry to find Zoe a match.

Anyone between the ages of 17 and 35 with a Canadian health card can be swabbed. However, Dudzianiec says doctors have told them they need people of Middle Eastern descent to get tested to increase the odds of finding a match for Zoe.

My Dad is Middle Eastern, and so they said it could be tricky for Zoe, Heidi said. If you think about it, theyre probably not doing swab events and things [in the Middle East] so theres not a lot of people of Middle Eastern descent on the world-wide registry.

Zoe is one of 900 Canadians looking for a stem cell or bone marrow transplant.

Anyone who cannot make the event this weekend can request a swabbing kit be mailed to their home by visiting the Canadian Blood Services website.

View original post here:
Tecumseh girl still looking for bone marrow donor - BlackburnNews.com

Leukemia: Know the risk factors to keep the disease at bay – TheHealthSite

Are you experiencing fever and persistent fatigue? Do you also losing weight and have pain in bones? If yes, you are suffering from leukemia, which is a cancer of the bone marrow and lymphatic system. In leukemia, the bone marrow produces abnormal white blood cells. They do not work properly. There are various types of leukemia and based on which the symptoms differ. Some of the common signs of this condition include weakness, chills, swollen lymph nodes, red spot on skin, tenderness sin bones etc. Notably, leukemia is one of the most common cancers in children. The condition occurs when DNA of white blood cells get damaged due to unknown reasons. This damage leads to uncontrollable division of these cells. Also, they do not die when they are supposed to. As far as its diagnosis is concerned, doctors perform physical exam, blood test, and bone marrow test to confirm the condition. For the treatment of leukemia, various options are available. Some of them include chemotherapy, biological therapy, targeted therapy, radiation therapy, stem cell transplant etc. To prevent any suffering, it is important to be aware about its risk factors. Read on to know about them.

Continued here:
Leukemia: Know the risk factors to keep the disease at bay - TheHealthSite

NI teen’s devastating cancer diagnosis days after dream Taylor Swift trip – Belfast Live

She had just celebrated becoming a teenager with a dream trip to see one of her favourite singers Taylor Swift perform all her hits.

But just days later, Lauren Fitzgerald's world was turned upside down when doctors revealed a pain in her side was actually stage 4 high risk neuroblastoma.

Since those special 13th birthday celebrations in Dublin in June last year, the Newry girl has undergone 15 gruelling months of treatment.

This has included chemotherapy, surgery, a stem cell transplant, radiotherapy and immunisation, which will finish this month.

But despite everything she has been through, the brave 14-year-old wants to help others and is calling on the public to clear out their wardrobes to help more children and young people survive cancer.

She is supporting TK Maxxs Give Up Clothes For Good campaign, in support of Cancer Research UK for Children & Young People.

Mum Mary Clare said: "It's thanks to research that Lauren is here today.However, despite intensive treatment, too few children are cured, and many suffer lifelong health problems.

"Research is needed into more effective and less harmful treatments for all childhood cancers.Thats why raising money for Cancer Research UK for Children & Young People is so important.

"Lauren and I will be having a good clear out at home and finding clothes and items to donate to our local TK Maxx store at Merchants Quay. I hope everyone will get behind this vitally important campaign and turn something they no longer need into funds for such a fantastic cause."

Lauren's life changed forever after marking her 13th birthday with the perfect trip to Dublin to see Taylor Swift at Croke Park with her mum and sister Niamh last June.

Just two days later she took a pain in her side and within a week of enjoying her birthday treat, her parents were told she had cancer. A few days later the pain was so great she was unable to walk.

Laurens diagnosis was terrifying for Mary Clare, an accountant who had to give up her job to care for Lauren, dad Garrett, who runs a sandwich business, Niamh (18) and brothers Sean (16) and James (20).

Lauren had a tumour on her adrenal gland and the disease spread to her bones and blood.

A hard-hitting 15-month course of treatment started immediately and Lauren has endured a gruelling year coming through chemotherapy, surgery, radiotherapy, a stem cell transplant, as well as numerous blood and platelet transfusions.

She has spent months in hospital unable to walk due to pain and weakness because of the disease and treatments.

Mum Mary Clare said: "Back in June 2018 Lauren was a typical teenager. She is a pupil of Sacred Heart School and likes drama, computers, reading and Lego. She has a wide circle of friends and had just started to go to a couple of teen discos.

"She was 13 on June 13, 2018 and on June 16 we went to see Taylor Swift in Croke Park for her birthday.

"On June 18 she was doing her exams when the school rang to say she had a pain in her side. She is a child who was never ill so I thought it was a bit strange and I took her to the doctor.

"The GP referred us to A&E with a suspected appendicitis and they told us at Daisy Hill it could also be muscular and if it didnt go away in a week we were to go back to the hospital.

"Two days later the pain was much worse and on June 21 Lauren was admitted to Daisy Hill for tests. She had a CT scan that showed she had a 9cm tumour near her kidney and two days later she was transferred to the Royal Hospital for Sick Children."

Lauren went through a batch of tests including an MRI, a biopsy, lumber puncture and MIBG scan, which revealed the devastating news that she had stage 4 high risk neuroblastoma.

Her mum added: "We were all in shock. I had never even heard of neuroblastoma or personally known another child with cancer.

"I went online to find out more and what I read was really frightening. Teenagers Google everything and I was terrified of what Lauren would read.

"The consultant advised us to be as open as possible with her and he actually explained the illness to her and the treatments. She asked could she still go to school and was so upset when he said not for at least another year.

"She was very teary, and it is hard to get your head around it. She was in a lot of pain and unable to walk at that stage and all she wanted was for the pain to stop."

Lauren started chemotherapy on July 5, less than three weeks after she had the first pain.

She had eight cycles over 80 days. Her hair fell out after the second cycle as her health got worse.

Her blood counts dropped and she needed numerous blood and platelet transfusions.

In October she underwent a seven-hour surgery to remove the primary tumour, which was a success, and then faced a course of high dose chemotherapy every six hours for five days.

This was followed by a stem cell transplant after which she had to spend three weeks in isolation.

In January of this year she started 14 days of radiotherapy and has just had her first immunisation treatment, which will finish this month.

Each year, around 140 young people under 25 years old are diagnosed with cancer in the Northern Ireland.

Jean Walsh,Cancer Research UK spokesperson for Northern Ireland, said: More children and young people than ever are surviving cancer, but theres still so much more to do.

Cancer in children and young people is different to cancer in adults from the types of cancer to the impact of treatment and the long-term side effects survivors often experience. So, it needs different, dedicated research which campaigns like Give Up Clothes For Good help to fund.

Cancer Research UK has funded many of the worlds most successful clinical trials for childrens and young peoples cancer treatments and continues to support vital ongoing research and clinical trials looking at improving survival and treatment.

We want to help more children and young people across Northern Ireland survive cancer with a good quality of life.

Thats why we hope as many people as possible will show their support and donate any quality clothes or goods to their local TK Maxx store. Unwanted items really could save lives.

People can donate at any TK Maxx store, all year round, includingthe store at Unit A, 41/45 Merchants Quay, Newry.

Supporters can also help raise funds by wearing a gold ribbon badge the awareness symbol of Childhood Cancer Awareness Month available from TK Maxx and Cancer Research UK stores throughout September.

Keep up-to-date with all the very latest news, what's on, sport and everything else in Belfast and beyond with the Belfast Live app.

Only select news that interests you by picking the topics you want to display on the app's homepage. Plus, our enhanced user experience includes live blogs, video, interactive maps and slick picture galleries. Download it now and get involved.

Click here to get it from the App Store or here for Google Play .

Read more:
NI teen's devastating cancer diagnosis days after dream Taylor Swift trip - Belfast Live

Buy PRP Kits & Stem Cell Therapy Supplies for Regenerative …

Details:

Apex Biologix understands the challenges of increased medical supply costs and a patients desire to receive quality care at an affordable cost. XCELL PRP was designed to deliver on those needs. No longer do you have to choose between a low-cost PRP system with low concentration numbers and an overpriced priced system.

Ease of Use

Using our patented processing accessories (lead screw, benchtop processing station) you can easily capture the buffy coat through a convenient push method. The buffy coat layer and easier-to-read markings on the kit allow a user to accurately obtain reproducible results consistently. Overall processing time is quicker, has fewer steps than most systems on the market, and fits into many centrifuge systems.

Kit Contents

2 - SYRINGE 60CC (LUER LOCK) 1 - NEEDLE 18G X 1" 1 - SYRINGE 12CC (LUER LOCK) 1 - Luer, 45 Degree Bent, Dispensing Tip 1 - APEX P60A Concentrating Device 1 - APEX P60A Cap 4 - ALCOHOL PREP PAD - NON-STERILE SOLUTION 5 - GAUZE SPONGE 4 X 4-8 PLY 2 - ADHESIVE BANDAGE 1 - LATEX FREE TOURNIQUET 1 - ABSORBENT TOWEL 2 - GLASSINE BAG 1 - HOSPITAL WRAP 1 - HEADER BAG 1 - MEDIUM POWDER-FREE SYNTHETIC GLOVE LATEX FREE 1 - YELLOW FACE MASK EARLOOPS 3 - UNIVERSAL MALE/FEMALE NON-VENTED CAP 1 - MALE LUER CAP 4 - WHITE BLANK LABEL

Available Sizes and Product Number:

Here is the original post:
Buy PRP Kits & Stem Cell Therapy Supplies for Regenerative ...

LifeCell – India’s First and Largest Stem Cell Bank

LifeCell is a research-intensive premier biotech company driven by the power of medical science and innovation for 14 years. As an extension of our commitment towards the healthcare sector, LifeCell has expanded its newest division, Biologics. LifeCell Biologics focuses to cater a wide range of placental tissue derived therapeutic products to provide solutions to enhance patient life expectancy and reduce global disease burden.

We are dedicated towards pushing the boundaries of science to develop and deliver life-changing health care products to make a difference in the life of patients while reducing the average cost of healthcare. In addition to our current product AmchoPlast, LifeCell Biologics is expecting to launch a series of products derived from placental tissues which are presently under rigorous research and developmental pipeline.

Our research design and practices are fabricated to exceed the industry standard globally. A perfect blend of state-of-art research, extremely talented team and hi-tech manufacturing infrastructure have enabled us to stand alone as a well-recognized leading biotech company.

Read more:
LifeCell - India's First and Largest Stem Cell Bank